Metabonomics: The future of personalized healthcare in liver intensive care?

0Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.

Abstract

Metabonomics involves the use of high-resolution analytical platforms to characterize the low-molecular-mass metabolic composition of biofluids and tissues. The resulting complex metabolic phenotype data are modelled using multivariate statistical approaches to identify systems levels panels of metabolites that discriminate between phenotypes (metabotypes), providing mechanistic insight and candidate biomarkers. With the increasing incidence of liver cirrhosis nationally, the pressures on NHS liver units is set to intensify, with mortality rates in these patients remaining high. This article describes a personalized medicine approach to stratify patients' mortality risk using metabolic phenotyping. This could aid doctors in clinical decision-making for patient transplant candidacy and critical care management to improve current survival rates.

Cite

CITATION STYLE

APA

Zia, R., Coen, M., McPhail, M., & Wilson, I. (2016). Metabonomics: The future of personalized healthcare in liver intensive care? Biochemist, 38(1), 27–30. https://doi.org/10.1042/bio03801027

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free